Aciculin inhibitors represent a class of chemical compounds that have garnered attention in the realm of molecular biology and cellular research. These inhibitors are specifically designed to target and modulate the activity of aciculin, a protein with diverse functions within the cell. Aciculin, also known as alpha-parvin, is a cytoskeletal protein that plays a crucial role in the organization and stabilization of the actin cytoskeleton. It acts as an adapter protein, linking integrins to actin filaments, and is involved in various cellular processes, including cell adhesion, migration, and the formation of focal adhesions. Aciculin's multifaceted role in cellular dynamics makes it an intriguing target for research, as its modulation can have far-reaching implications in understanding fundamental cellular processes.
Aciculin inhibitors exert their effects by interfering with the interactions between aciculin and its binding partners, disrupting the protein's ability to function within the actin cytoskeleton. This disruption can lead to alterations in cell adhesion, migration, and the overall stability of the cytoskeleton. Consequently, these inhibitors serve as valuable tools in the investigation of the molecular mechanisms governing cell motility, adhesion, and cytoskeletal dynamics. Researchers employ aciculin inhibitors to explore the intricate network of protein-protein interactions that underlie these essential cellular processes, shedding light on the broader implications of aciculin dysfunction in various physiological contexts. While the specific applications and implications of aciculin inhibitors continue to be a subject of ongoing research, their utility in elucidating the role of aciculin within the cellular machinery is undeniably significant.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
2-Deoxy-D-glucose | 154-17-6 | sc-202010 sc-202010A | 1 g 5 g | $70.00 $215.00 | 26 | |
A glucose analog that may competitively inhibit enzymes like PGM5, potentially reducing its expression due to feedback inhibition. | ||||||
N-Acetyl-D-glucosamine | 7512-17-6 | sc-286377 sc-286377B sc-286377A | 50 g 100 g 250 g | $94.00 $162.00 $306.00 | 1 | |
This monosaccharide derivative could affect glycosylation processes, potentially impacting PGM5 expression or function. | ||||||
Alloxan monohydrate | 2244-11-3 | sc-254940 | 10 g | $54.00 | ||
Alloxan selectively inhibits glucose-regulated enzymes and pathways, which might influence PGM5 expression. | ||||||
Streptozotocin (U-9889) | 18883-66-4 | sc-200719 sc-200719A | 1 g 5 g | $116.00 $530.00 | 152 | |
Known to target pancreatic beta cells, its influence on glucose metabolism could affect PGM5 expression in muscle tissue indirectly. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
As an mTOR inhibitor, rapamycin can affect protein synthesis, which may indirectly lead to reduced PGM5 expression. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
An MEK inhibitor which might affect MAPK/ERK pathway, potentially downregulating PGM5 expression through this signaling pathway. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
An inhibitor of p38 MAP kinase, which could influence transcription factors that regulate PGM5 expression. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
A JNK inhibitor that could modulate transcription factors and, consequently, the expression of PGM5. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A PI3K inhibitor, LY294002 might reduce PGM5 expression by affecting the AKT signaling pathway which is involved in protein synthesis. | ||||||
Wiskostatin | 253449-04-6 | sc-204399 sc-204399A sc-204399B sc-204399C | 1 mg 5 mg 25 mg 50 mg | $49.00 $124.00 $441.00 $828.00 | 4 | |
A GLUT1 inhibitor that could lower intracellular glucose levels, potentially affecting PGM5 expression by altering glucose metabolism. | ||||||